Citigroup’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Citigroup's RMD Position: Q3 2026 in Review
Citigroup increased its ResMed (RMD) stake by 20% in Q3 2026, buying an estimated $33.2M and bringing the position to 926,758 shares worth $205M. The position accounts for 0.07% of the portfolio, ranked #271.
Citigroup first reported a position in RMD in Q2 2013 and has held it in 54 quarters since. 880 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Citigroup held 926,758 shares of ResMed worth $205M as of Q3 2026.
- Citigroup bought 152,333 ResMed shares in Q3 2026, an estimated $33.2M.
- ResMed made up 0.07% of Citigroup's portfolio in Q3 2026, its #271 holding.
- Citigroup first reported a position in ResMed in Q2 2013 and has held it in 54 quarters since.
- 880 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.